James River Group Ltd. (JRVR) Business Metric Overview - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    James River Group Ltd.

    NASDAQ: JRVR · Real-Time Price · USD
    5.57
    0.03 (0.54%)
    At close: Sep 26, 2025, 3:59 PM
    5.57
    0.00%
    After-hours: Sep 26, 2025, 04:10 PM EDT

    James River Revenue Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Excess And Surplus Lines Revenue 158.32M 151.54M 262.02M 163.49M 159.57M 168.92M 171.19M 177.03M 175.52M 166.65M 164.09M 140.95M 131.66M 133.39M 138.41M 127.6M 124.02M 118.8M 119.95M 112.8M 113.34M 83.83M 175.76M 170.73M 158.57M 152.44M 146.64M 149.81M 147.01M 137.33M 242.16M 131.03M 125.48M 101.09M 62M 88.67M 78.94M 71.79M 52.19M 70.12M 57.53M 61.04M
    Excess And Surplus Lines Revenue Growth +4.48% -42.17% +60.27% +2.45% -5.53% -1.33% -3.30% +0.86% +5.32% +1.56% +16.42% +7.05% -1.30% -3.63% +8.47% +2.89% +4.40% -0.96% +6.34% -0.48% +35.21% -52.30% +2.94% +7.67% +4.03% +3.95% -2.11% +1.90% +7.05% -43.29% +84.81% +4.42% +24.13% +63.04% -30.08% +12.33% +9.96% +37.55% -25.56% +21.88% -5.75% n/a
    Specialty Admitted Insurance Revenue 16.17M 20.1M 51.52M 26.42M 28.05M 31.54M 34M 32.94M 28.33M 24.51M 22.44M 19.6M 19.19M 20.36M 23.19M 21.01M 21.09M 18.57M 17.4M 16.84M 15.87M 12.67M 16.07M 16.49M 14.94M 13.74M 12.93M 14.4M 15.44M 13.96M 27.77M 19.99M 18.43M 16.92M n/a 13.89M 13.33M 12.05M n/a 11.46M 48.84M 52.15M
    Specialty Admitted Insurance Revenue Growth -19.56% -60.99% +94.98% -5.82% -11.04% -7.24% +3.22% +16.27% +15.59% +9.22% +14.48% +2.16% -5.78% -12.18% +10.37% -0.40% +13.62% +6.67% +3.33% +6.13% +25.23% -21.15% -2.55% +10.39% +8.77% +6.27% -10.24% -6.71% +10.61% -49.76% +38.93% +8.45% +8.93% n/a n/a +4.21% +10.64% n/a -100.00% -76.53% -6.34% n/a

    Operating Expense Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue 161.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a 13.12M n/a n/a n/a 11.76M n/a n/a n/a 12.63M n/a n/a n/a 12.38M n/a n/a n/a -54.78M n/a n/a 54.78M 7.69M n/a n/a n/a 5.49M n/a n/a n/a 4.01M n/a n/a n/a
    Selling, General, and Administrative Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a -100.00% +612.58% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a n/a
    Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist